Welcome to Advanced Biomedical

ABL has developed an innovative technology that dramatically speeds up the process of identifying infected surfaces within healthcare settings, following the completion of an innovation call from the Technology Strategy Board (TSB). Current conventional laboratory tests take three days to confirm whether a surface was colonised with an HCAI but ABLís innovation is now able to ascertain endospore contamination within 1 hour.
The prototype hand held device utilises magnified images of fluorescent microspots to determine infectious disease. At the heart of the technology, is a glow reagent to illuminate potentially viable endospores from within its nanocore compartments. The device can be easily transported by infection control staff to any desired location. Following a short procedure the device offers a positive or negative reading. More info
Spore Detection

Company Registered in England. Number 04690930
© 2003-2014 Advanced Biomedical Ltd. ē Disclaimer